This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Radiation Toxicity Treatment Market

Market Insights on Radiation Toxicity Treatment covering sales outlook, demand forecast & up-to-date key trends

Radiation Toxicity Treatment Market by Product (Colony Stimulating Factors, Potassium Iodide, Prussian Blue, Diethylenetriamine Penta acetic Acid, and Others), Radiation Type (Ionizing and Non-Ionizing Radiation), By Indication- (Acute Radiation Syndrome, Chronic Radiation Syndrome) & Region for 2022-2029

Radiation Toxicity Treatment Market Outlook (2022-2029)

[194 Pages Report] The global Radiation Toxicity Treatment Market was valued at US$ 3.55 Bn in 2021 and is expected to reach US$ 5.58 Bn by 2029, finds Future Market Insights (FMI) in a recent market survey.

Market Outlook:

Data Points

Market Insights

Market Value 2022

USD 3.76 Bn

Market Value 2029

USD 5.58 Bn

CAGR 2022-2029

5.8%

Share of Top 5 Countries

57.4%

Key Players

The key players in radiation toxicity treatment market are Amgen, Jubilant Life Sciences, Siegfried Holdings , Heyl Chemisch-pharmazeutische Fabrik GmbH & Co. KG, Recipharm AB, Mission Pharmacal Company, Partner Therapeutics, Inc., Novartis AG, Mylan NV

Cancer is one of the leading causes of death around the world. The global prevalence of cancer is continuously increasing, increasing the demand for radiotherapy as a therapeutic option. Being exposed to radiations during radiotherapy causes radiation toxicity.

As per the previous decade's trend, around 50% of patients with liver cancer, colon cancer, pancreatic cancer, and prostate cancer were treated with radiotherapy. Radiotherapy not only destroys tumor cells, but it also destroys normal and healthy cells in the proximity of the tumor. This is the primary cause of radiation toxicity in 60% of individuals who receive radiotherapy. As a result, with the rising prevalence of cancer, the number of cases of radiation toxicity is also increasing around the world.

Significant investments in nuclear energy in some countries have been increased in recent years, resulting in more nuclear facilities, which has raised the risk of individuals being exposed to radiation. The radiotherapy coverage policies and reimbursements provide easy access to radiotherapy treatments.

Increased usage of positron emission tomography (PET) and single photon emission computed tomography (SPECT) scanners in hospitals and diagnostic centers increases radiation toxicity due to gamma radiation emission, which provides a potential growth opportunity for the radiation toxicity market.

Customize this Report

Let us know your requirement to get
100% FREE customization

How The Market Progressed Till June 2022?

Particulars

Details

H1, 2021

5.74%

H1, 2022 Projected

5.79%

H1, 2022 Outlook

5.69%

BPS Change - H1, 2022 (O) – H1, 2022 (P)

(-) 10 ↓

BPS Change – H1, 2022 (O) – H1, 2021

(-) 05 ↓

Regulatory compliances and clinical outcomes of treatment are dynamics which impact the market for radiation toxicity treatment. The market is subject to be influenced by macro, regulatory, and industrial factors. Developing radiation-drug combinations, and implementation of non-ionic radiations for therapeutic use are key market developments.

According to FMI analysis, the radiation toxicity treatment market will show a decline in H1-2022 (O) growth rate as compared H1-2021 by nearly 5 BPS. Additionally, comparison of the growth rate for the projected H1-2022 and Outlook H1-2022 period also showed a dip by nearly 10 BPS.

Acute radiation damage, distal atrophy and necrosis, and radiation injury are factors which are leading towards a reduction in the BPS value for the radiation toxicity treatment market.

Development of treatment systems that use modulated beams of photons and protons to improve cancer outcomes by irradiating cancerous tissues in ways that lead to improved control of tumors and by reducing doses to healthy tissues to reduce treatment complications are two key factors which display a progressive approach towards growth for the overall radiation toxicity treatment market.

Conversely, other market segments are expected to perform objectively and achieve lucrative growth prospects in the next half of projection period, owing to the clinical development of novel drug-radiotherapy.

2014-2021 Market Demand Outlook for Radiation Toxicity Treatment compared to 2022-2029 Forecast

Sales of radiation toxicity treatment market grew at a CAGR of 4.9% between 2014 and 2021. In 2021, the global market of radiation toxicity treatment accounts for approx. 38% of the overall toxicology drug screening market that accounts for around US$ 9.4 Bn.

Radiation used in the treatment also damages the healthy cells present around cancer tumors in the human body, resulting into side effects such as dry mouth, mouth and gum sores, difficulty in swallowing, stiffness in the jaw, nausea, and others, after a duration ranging from days, months, to years.

For the prevention of damage to the healthy cells, radiologists and dosimetrists are focusing on using software such as treatment planning software, radiation dose management, and others for providing the right amount of radiation doses to the patients at targeted locations, without harming the healthy cells around the tumor.

With technological evolution in the field of radiation, automation is successfully implemented in radiotherapy. Radiation therapy centers are increasingly using advanced software, such as treatment planning software, for developing a treatment plan for each beamline route for estimating the direction in which the therapy system will deliver radiotherapy to a patient hence, the demand for radiation toxicity treatment will increase and will drive the market.

The radiation toxicity treatment market is expected to grow in the future, as the healthcare profession continues to evolve as a result of the need to discover newer technologies to effectively diagnose any issue.

Radiation Toxicity Treatment Market Download Report Brochure

In addition, the market's growth is expected to be boosted by rising acceptance and quick expansion of new technologies in emerging economies throughout the forecast period. Leading companies are concentrating their efforts on the launch of new products as well as research and development.

Considering this, FMI expects the global radiation toxicity treatment to grow at a CAGR of 5.8% through 2029.

Which Factors Are Restraining the Demand for radiation toxicity treatment?

Lack of guidance regarding rare diseases such as acute radiation syndrome-specific research methodologies and identifying patients for study specially including very impaired or minimally impaired patients in research remains a challenge.

There also exist various legal and ethical issues to find adequate sample size for clinical research. Selecting appropriate outcomes and their measurement is difficult due to heterogeneity in treatment and effect of various diseases in patients due to absence of validated outcome. Also, lack of disease knowledge and diversity in terms of epidemiology, diagnosis, prognosis and treatment affects the clinical trial design and planning.

In cases of rare diseases such as acute radiation syndrome, the patient–physician relationship may not fit with the traditional assumptions of medical care. The lack of disease-related expertise among healthcare professionals and psychological challenges associated with the diagnosis of an incurable disease may lead to improper treatment. Due to poor knowledge of rare diseases and limited therapeutic options of treatments, physicians may not act as competent technical experts who provide relevant information to patients.

To avoid this, disease specialist should be trained to deal with patients with rare diseases and they must learn to cope with assertive and well-informed expert patients. Educational associations and institutions in healthcare should encourage physicians to practice and improve their skills in this area.

This can prove to be a major restraining factor for the product segment of the radiation toxicity treatment market.

What is the Impact of the COVID-19 Crisis on the Radiation toxicity treatment Market?

The radiotherapy market is growing slowly as a result of the coronavirus pandemic, since the healthcare community's focus has changed from chronic diseases in limiting the transmission of COVID-19. As a result, a number of cancer-specialty hospitals have closed or been converted to COVID care centers. Furthermore, the import and export of radiotherapy systems have been severely hampered by the uncertain supply chain.

However in 2021, as the recovery began, some hospitals reopened their cancer units, which increased the number of radiotherapy treatments. After the second wave, a large number of population got treated for radiotherapy which augmented the growth of radiation toxicity treatment market.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Country-wise Insights

What Makes the U.S. the Largest Market for radiation toxicity treatment?

In 2021, the U.S. dominated the North American market, with more over 91% of the market share. The United States has the largest market for radiation toxicity treatment. The market is driven by factors such as rising cancer incidence and mortality, the replacement of older therapies with newer ones, and the provision of reimbursements for radiation toxicity therapy, the U.S is expected to reflect similar market trends over the projection timeframe.

Furthermore, in the United States, the implementation of safety rules and policies, improved treatment outcomes of radiation toxicity therapy, and significant investments by key manufacturers in product development and distribution are boosting radiation toxicity treatment market growth.

Why is Germany Considered a More Lucrative Market for Radiation Toxicity Treatment in Europe?

Germany dominated the European radiation toxicity treatment market and accounted for approx. 20.6% of market share in 2021, owing to increased use of PET and single-photon emission computed tomography scanning machines across various diagnostic centers. Furthermore, favorable health coverage policies and stringent regulations have boosted the market growth in the region.

While Europe is identified as a lucrative market, stakeholders are particularly eying the profits in East and South Asia. These regional markets are turning attractive with the increasing per capita healthcare expenditure and multiple government programs for integrated healthcare systems.

What are the Factors Fueling the Demand for Radiation Toxicity Treatment in China?

The radiation toxicity treatment market in China is projected to grow at a 10.4% CAGR in East Asia throughout the forecast period. Rising awareness about advanced radiation toxicity treatments, as well as improving healthcare infrastructure, are expected to fuel the growth of the China radiation toxicity treatment market throughout the forecast period.

Furthermore, China's radiation toxicity treatment market is expected to rise at a faster rate by 2029 as a result of a strong focus on research and development in the region.

What Makes India an Emerging Market for Radiation Toxicity Treatment?

India is an emerging market for radiation toxicity treatment and account for the largest share for more than 48% in South Asia radiation toxicity treatment market due to improving healthcare infrastructure, large patient base for target diseases, and growing presence of leading market players in the region to grab advantage of the rising opportunities given in India. These are the main drivers of radiation toxicity treatment market growth in this region.

Category-wise Insights

Why Colony Stimulating Factors accounts for the highest share by Product?

Colony stimulating factors is the leading segment and expected to gain more than 78% of revenue share in 2021 owing to the increasing adoption of colony-stimulating factors (CSFs). The management of febrile neutropenia in cancer patients has become increasingly important as chemotherapy doses have been increased and the variety of available treatment lines has grown. Colony-stimulating factors (CSFs) are growth hormones that prevent chemotherapy-induced neutropenia. They include granulocyte-colony stimulating factors (G-CSF) and granulocyte macrophage-colony stimulating factors (GM-CSF). They are utilized in frail patients undergoing chemotherapy and patients undergoing highly haematotoxic programs.

Why do Acute Radiation Syndrome Contribute the Highest Market Share by Indication?

Acute radiation syndrome are caused by irradiation of the entire body by a high dose of penetrating radiation in a very short period of time. The acute radiation syndrome segment by indication is projected to account for 87.8% of the total market share in 2021 as acute radiation syndrome is highly progressive by nature and can effects the patients in less than 24 hours of exposure to radiation.

Why Ionizing Radiation Contribute to the highest market share by Type of Radiation?

Representing a whopping 89.6% share in global market in 2021, ionizing radiation remains the highly preferred radiation toxicity treatment, particularly in developed countries. On the other side, it also continues to witness growing traction within developing regional markets. Under ionizing radiation, gamma radiation method accounts for over 55.8% share, while alpha and beta radiation methods are observing significant adoption.

Which End User will be Most Preferred?

Hospital segment accounts for the highest share of over 88% in 2021 by end user due to increasing adoption and increasing footfalls to seek effective radiation toxicity treatment at hospitals, availability of advance devices and presence of qualified medical personnel in the hospital.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Competitive Landscape

The global radiation toxicity treatment market is highly consolidated. Leading players of the radiation toxicity treatment market are also emphasizing on collaboration with distributor or local manufacturer to enhance their distribution channel in emerging economies.

For instance, In September 2020, the AI-Rad Companion Organs RT, the latest AI-Rad Companion artificial intelligence-based software assistant from Siemens Healthineers, has received FDA approval. As part of the radiation therapy planning workflow, AI-Rad Companion Organs RT uses deep-learning AI algorithms to autonomously outline organs at risk (OARs) on computed tomography (CT) images, facilitating precision medicine.

In May 2018, Partner Therapeutics signed distribution agreement with Tanner Pharma Group for the distribution of Leukine in the areas outside the U.S. and Canada.

In January 2017, Jubilant Life Sciences Limited signed a long-term contract with distribution networks in the US for supply of products used for diagnostic and therapeutic products with Montreal Canada (JDI).

Scope of the Report

Attribute

Details

Forecast Period

2022-2029

Historical Data Available for

2014-2021

Market Analysis

USD Million for Value

Key Regions Covered

North America, Latin America, Europe, South Asia and  Pacific, East Asia and Middle East & Africa

Key Countries Covered

US, Canada,  Brazil,  Mexico, Argentina, Germany, U.K., France, Italy, Spain,  Benelux, Russia, China, Japan, South Korea, India, Thailand, Indonesia, Malaysia, Thailand, Indonesia, Australia and New Zealand, Egypt, Turkey, South Africa, North Africa and GCC Countries

Key Segments Covered

Product, Indication, End User, Radiation and Region

Key Companies Profiled

  • Amgen
  • Partner Therapeutics, Inc.
  • Novartis AG
  • Mylan NV
  • Coherus BioSciences Inc.
  • Jubilant Life Sciences
  • Siegfried Holdings
  • Heyl Chemisch-pharmazeutische Fabrik GmbH & Co. KG
  • Recipharm AB
  • Mission Pharmacal Company

Report Coverage

Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives

Customization & Pricing

Available upon Request

Radiation toxicity treatment Market by Category

By Product :

  • Colony Stimulating Factors
  • Potassium Iodide
  • Prussian Blue
  • Diethylenetriamine Pentaacetic Acid
  • Others

By Indication :

  •  Acute Radiation Syndrome
    • Bone Marrow Syndrome (Hematopoietic)
    • Gastrointestinal Syndrome (GI)
    • Cardiovascular (CV)
  • Chronic Radiation Syndrome

By Radiation Type :

  • Ionizing Radiation
    • Alpha Radiation
    • Beta Radiation
    • Gamma Radiation
  • Non-ionizing Radiation

By End-User :

  • Hospitals
    • Government Hospitals
    • Private Hospitals
  • Research & Academic Institutes
    • Government Research and Academic Institutes
    • Private Research and Academic Institutes

By Region :

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa (MEA)

Frequently Asked Questions

The global radiation toxicity treatment market is worth US$ 3.55 Bn in 2021 and is set to expand 1.5X over the next 7 years.

The radiation toxicity treatment market is expected to reach US$ 5.58 Bn by the end of 2029, with sales revenue expected to grow at a 5.8% CAGR.

Increasing number of PET and SPECT scanners, continuous drug approvals for radiation toxicity treatment and increasing burden of cancer worldwide are the factors driving the demand outlook of the global radiation toxicity market.

North America currently holds the largest market share of 38.0% in 2021 in the radiation toxicity treatment market globally.

U.S., Japan, China, Germany, and India are the top 5 countries that are driving the demand for radiation toxicity treatment market.

Amgen, Partner Therapeutics, Inc., Novartis AG, Mylan NV, Coherus BioSciences Inc, Jubilant Life Sciences, Siegfried Holdings, Heyl Chemisch-pharmazeutische Fabrik GmbH & Co. KG, Recipharm AB and Mission Pharmacal Company are the leading players in the market.

Japan’s market is expected to exhibit healthy growth of 6.9% CAGR during the forecast period.

Demand of radiation toxicity treatment is expected to register growth rate of 4.7% during the forecast period in European market.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Supply-side Trends

    1.3. Demand-side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Dynamics

    3.1. Macro-Economic Factors

    3.2. Drivers

        3.2.1. Supply Side Drivers

        3.2.2. Demand Side Drivers

    3.3. Restraints

    3.4. Opportunities

4. Key Inclusion

    4.1. FDA Approved Drugs

    4.2. Pipeline Assessment

    4.3. Therapeutic Efficacy and Treatment Metrics

    4.4. Predisposing Factors

5. Global Radiation Toxicity Treatment Market Value Analysis 2014-2021 and Forecast, 2022-2029

    5.1. Historical Market Value (US$ Mn) Analysis, 2014-2021 

    5.2. Current and Future Market Value (US$ Mn) Projections, 2022-2029

        5.2.1. Y-o-Y Growth Trend Analysis

        5.2.2. Absolute $ Opportunity Analysis

6. Global Radiation Toxicity Treatment Market Analysis 2014-2021 and Forecast 2022-2029, by Product

    6.1. Introduction / Key Findings

    6.2. Historical Market Size (US$ Mn) Analysis by Product, 2014-2021 

    6.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Product, 2022 - 2029

        6.3.1. Colony Stimulating Factors

        6.3.2. Prussian Blue

        6.3.3. Diethylenetriamine Pentaacetic Acid

        6.3.4. Potassium Iodide

        6.3.5. Others

    6.4. Market Attractiveness Analysis by Product

7. Global Radiation Toxicity Treatment Market Analysis 2014-2021 and Forecast 2022-2029, by Indication

    7.1. Introduction / Key Findings

    7.2. Historical Market Size (US$ Mn) Analysis by Indication, 2014-2021 

    7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Indication, 2022 - 2029

        7.3.1. Acute Radiation Syndrome (ARS)

            7.3.1.1. Bone Marrow Syndrome (Hematopoietic)

            7.3.1.2. Gastrointestinal Syndrome (GI)

            7.3.1.3. Cardiovascular (CV)

            7.3.1.4. Central Nervous System (CNS) Syndrome

        7.3.2. Chronic Radiation Syndrome

    7.4. Market Attractiveness Analysis by Indication

8. Global Radiation Toxicity Treatment Market Analysis 2014-2021 and Forecast 2022-2029, by Radiation

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Mn) Analysis by Radiation, 2014-2021 

    8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Radiation, 2022 - 2029

        8.3.1. Acute Radiation Syndrome (ARS)

            8.3.1.1. Bone Marrow Syndrome (Hematopoietic)

            8.3.1.2. Gastrointestinal Syndrome (GI)

            8.3.1.3. Cardiovascular (CV)

            8.3.1.4. Central Nervous System (CNS) Syndrome

        8.3.2. Chronic Radiation Syndrome

    8.4. Market Attractiveness Analysis by Radiation

9. Global Radiation Toxicity Treatment Market Analysis 2014-2021 and Forecast 2022-2029, by End User

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Mn) Analysis by End User, 2014-2021 

    9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by End User, 2022 - 2029

        9.3.1. Hospitals

            9.3.1.1. Government Hospitals

            9.3.1.2. Private Hospitals

        9.3.2. Research & Academic Institutes

            9.3.2.1. Government Research and Academic Institutes

            9.3.2.2. Private Research and Academic Institutes

    9.4. Market Attractiveness Analysis by End User

10. Global Radiation Toxicity Treatment Market Analysis 2014-2021 and Forecast 2022-2029, by Region

    10.1. Introduction

    10.2. Historical Market Size (US$ Mn) Analysis by Region, 2014-2021 

    10.3. Current Market Size (US$ Mn) Analysis and Forecast by Region, 2022 - 2029

        10.3.1. North America

        10.3.2. Latin America

        10.3.3. Europe

        10.3.4. East Asia

        10.3.5. South Asia

        10.3.6. Oceania

        10.3.7. Middle East & Africa

    10.4. Market Attractiveness Analysis by Region

11. North America Radiation Toxicity Treatment Market Analysis 2014-2021 and Forecast 2022-2029

    11.1. Introduction

    11.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2014-2021 

    11.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2029

        11.3.1. By Country

            11.3.1.1. U.S.

            11.3.1.2. Canada

        11.3.2. By Product

        11.3.3. By Indication

        11.3.4. By Radiation

        11.3.5. By End User

    11.4. Market Attractiveness Analysis

    11.5. Drivers and Restraints - Impact Analysis

12. Latin America Radiation Toxicity Treatment Market Analysis 2014-2021 and Forecast 2022-2029

    12.1. Introduction

    12.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2014-2021 

    12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2029

        12.3.1. By Country

            12.3.1.1. Brazil

            12.3.1.2. Mexico

            12.3.1.3. Argentina

            12.3.1.4. Rest of Latin America

        12.3.2. By Product

        12.3.3. By Indication

        12.3.4. By End User

    12.4. Market Attractiveness Analysis

    12.5. Drivers and Restraints - Impact Analysis

13. Europe Radiation Toxicity Treatment Market Analysis 2014-2021 and Forecast 2022-2029

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2014-2021 

    13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2029

        13.3.1. By Country

            13.3.1.1. Germany

            13.3.1.2. U.K.

            13.3.1.3. France

            13.3.1.4. Italy

            13.3.1.5. Spain

            13.3.1.6. Rest of Europe

        13.3.2. By Product

        13.3.3. By Indication

        13.3.4. By Radiation

        13.3.5. By End User

    13.4. Market Attractiveness Analysis

    13.5. Drivers and Restraints - Impact Analysis

14. East Asia Radiation Toxicity Treatment Market Analysis 2014-2021 and Forecast 2022-2029

    14.1. Introduction

    14.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2014-2021 

    14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2029

        14.3.1. By Country

            14.3.1.1. China

            14.3.1.2. Japan

            14.3.1.3. South Korea

        14.3.2. By Product

        14.3.3. By Indication

        14.3.4. By Radiation

        14.3.5. By End User

    14.4. Market Attractiveness Analysis

    14.5. Drivers and Restraints - Impact Analysis

15. South Asia Radiation Toxicity Treatment Market Analysis 2014-2021 and Forecast 2022-2029

    15.1. Introduction

    15.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2014-2021 

    15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2029

        15.3.1. By Country

            15.3.1.1. India

            15.3.1.2. Indonesia

            15.3.1.3. Thailand

            15.3.1.4. Malaysia

            15.3.1.5. Rest of South Asia

        15.3.2. By Product

        15.3.3. By Indication

        15.3.4. By Radiation

        15.3.5. By End User

    15.4. Market Attractiveness Analysis

    15.5. Drivers and Restraints - Impact Analysis

16. Oceania Radiation Toxicity Treatment Market Analysis 2014-2021 and Forecast 2022-2029

    16.1. Introduction

    16.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2014-2021 

    16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2029

        16.3.1. By Country

            16.3.1.1. Australia

            16.3.1.2. New Zealand

        16.3.2. By Product

        16.3.3. By Indication

        16.3.4. By Radiation

        16.3.5. By End User

    16.4. Market Attractiveness Analysis

    16.5. Drivers and Restraints - Impact Analysis

17. Middle East and Africa Radiation Toxicity Treatment Market Analysis 2014-2021 and Forecast 2022-2029

    17.1. Introduction

    17.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2014-2021 

    17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2029

        17.3.1. By Country

            17.3.1.1. GCC Countries

            17.3.1.2. South Africa

            17.3.1.3. Turkey

            17.3.1.4. Rest of MEA

        17.3.2. By Product

        17.3.3. By Indication

        17.3.4. By Radiation

        17.3.5. By End User

    17.4. Market Attractiveness Analysis

    17.5. Drivers and Restraints - Impact Analysis

18. Market Structure Analysis

    18.1. Tier Structure Analysis

    18.2. Market Concentration

    18.3. Company Share Analysis

    18.4. Company Footprint Analysis

19. Competition Analysis

    19.1. Competition Dashboard

    19.2. Competition Deep Dive

        19.2.1. Amgen

            19.2.1.1. Company Overview

            19.2.1.2. Analyst Commentary

            19.2.1.3. Product Overview

            19.2.1.4. Financial Analysis

            19.2.1.5. Key Developments

            19.2.1.6. Strategy Overview

        19.2.2. Partner Therapeutics, Inc.

            19.2.2.1. Company Overview

            19.2.2.2. Analyst Commentary

            19.2.2.3. Product Overview

            19.2.2.4. Financial Analysis

            19.2.2.5. Key Developments

            19.2.2.6. Strategy Overview

        19.2.3. Novartis AG

            19.2.3.1. Company Overview

            19.2.3.2. Analyst Commentary

            19.2.3.3. Product Overview

            19.2.3.4. Financial Analysis

            19.2.3.5. Key Developments

            19.2.3.6. Strategy Overview

        19.2.4. Mylan NV

            19.2.4.1. Company Overview

            19.2.4.2. Analyst Commentary

            19.2.4.3. Product Overview

            19.2.4.4. Financial Analysis

            19.2.4.5. Key Developments

            19.2.4.6. Strategy Overview

        19.2.5. Coherus BioSciences Inc

            19.2.5.1. Company Overview

            19.2.5.2. Analyst Commentary

            19.2.5.3. Product Overview

            19.2.5.4. Financial Analysis

            19.2.5.5. Key Developments

            19.2.5.6. Strategy Overview

        19.2.6. Jubilant Life Sciences

            19.2.6.1. Company Overview

            19.2.6.2. Analyst Commentary

            19.2.6.3. Product Overview

            19.2.6.4. Financial Analysis

            19.2.6.5. Key Developments

            19.2.6.6. Strategy Overview

        19.2.7. Siegfried Holdings

            19.2.7.1. Company Overview

            19.2.7.2. Analyst Commentary

            19.2.7.3. Product Overview

            19.2.7.4. Financial Analysis

            19.2.7.5. Key Developments

            19.2.7.6. Strategy Overview

        19.2.8. Heyl Chemisch-pharmazeutische Fabrik GmbH & Co. KG

            19.2.8.1. Company Overview

            19.2.8.2. Analyst Commentary

            19.2.8.3. Product Overview

            19.2.8.4. Financial Analysis

            19.2.8.5. Key Developments

            19.2.8.6. Strategy Overview

        19.2.9. Recipharm AB

            19.2.9.1. Company Overview

            19.2.9.2. Analyst Commentary

            19.2.9.3. Product Overview

            19.2.9.4. Financial Analysis

            19.2.9.5. Key Developments

            19.2.9.6. Strategy Overview

        19.2.10. Mission Pharmacal Company

            19.2.10.1. Company Overview

            19.2.10.2. Analyst Commentary

            19.2.10.3. Product Overview

            19.2.10.4. Financial Analysis

            19.2.10.5. Key Developments

            19.2.10.6. Strategy Overview

20. Assumptions and Acronyms Used

21. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: List of FDA Approved Drugs for Radiation Toxicity Treatment

Table 02: Pipeline Assessment for Radiation Toxicity Treatment Drugs (1/2)

Table 03: Pipeline Assessment for Radiation Toxicity Treatment Drugs (2/2)

Table 04: Acute Radiation Syndrome: A Fact Sheet

Table 05: Intrinsic Predisposing Factors for Radiotherapy-induced skin reactions

Table 06: Extrinsic Predisposing Factors for Radiotherapy-induced skin reactions

Table 07: Global Radiation Toxicity Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2014–2029, By Product

Table 08: Global Radiation Toxicity Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2014–2029, By Indication

Table 09: Global Radiation Toxicity Treatment Market Value (US$ Mn) Analysis- and Opportunity Assessment 2014–2029, By Radiation

Table 10: Global Radiation Toxicity Treatment Market Value (US$ Mn) Analysis- and Opportunity Assessment 2014–2029, By End User

Table 11: Global Radiation Toxicity Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2014–2029, By Country

Table 12: North America Radiation Toxicity Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country

Table 13: North America Radiation Toxicity Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product

Table 14: North America Radiation Toxicity Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Indication

Table 15: North America Radiation Toxicity Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Radiation

Table 16: North America Radiation Toxicity Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User

Table 17: Latin America Radiation Toxicity Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country

Table 18: Latin America Radiation Toxicity Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product

Table 19: Latin America Radiation Toxicity Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Indication

Table 20: Latin America Radiation Toxicity Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Radiation

Table 21: Latin America Radiation Toxicity Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User

Table 21: East Asia Radiation Toxicity Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User

Table 22: Europe Radiation Toxicity Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country

Table 23: Europe Radiation Toxicity Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product

Table 24: Europe Radiation Toxicity Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Indication

Table 25: Europe Radiation Toxicity Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Radiation

Table 26: Europe Radiation Toxicity Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User

Table 27: East Asia Radiation Toxicity Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country

Table 28: East Asia Radiation Toxicity Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product

Table 29: East Asia Radiation Toxicity Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Indication

Table 30: East Asia Radiation Toxicity Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Radiation

Table 32: South Asia Radiation Toxicity Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country

Table 33: South Asia Radiation Toxicity Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product

Table 34: South Asia Radiation Toxicity Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Indication

Table 35: South Asia Radiation Toxicity Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Radiation

Table 36: South Asia Radiation Toxicity Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User

Table 37: Oceania Radiation Toxicity Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country

Table 38: Oceania Radiation Toxicity Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product

Table 39: Oceania Radiation Toxicity Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Indication

Table 40: Oceania Radiation Toxicity Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Radiation

Table 41: Oceania Radiation Toxicity Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User

Table 42: MEA Radiation Toxicity Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country

Table 43: MEA Radiation Toxicity Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product

Table 44: MEA Radiation Toxicity Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Indication

Table 45: MEA Radiation Toxicity Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Radiation

Table 46: MEA Radiation Toxicity Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: Radiation Toxicity Market, Pipeline Analysis by Phase

Figure 02: Radiation Toxicity Market, Pipeline Analysis by Status

Figure 03: Radiation Toxicity Market, Pipeline Analysis by Funding Type

Figure 04: Radiation Toxicity Market, Pipeline Analysis by Region

Figure 05: Global Radiation Toxicity Treatment Market Value Analysis (US$ Mn), 2014-2021 

Figure 06: Global Radiation Toxicity Treatment Market Value Forecast (US$ Mn), 2022-2029

Figure 07: Global Radiation Toxicity Treatment Market Absolute $ Opportunity, 2022 - 2029

Figure 08: Global Radiation Toxicity Treatment Market Share Analysis (%), By Product, 2022 & 2029

Figure 09: Global Radiation Toxicity Treatment Market Y-o-Y Analysis (%), By Product, 2022-2029

Figure 10: Global Radiation Toxicity Treatment Market Attractiveness Analysis by Product, 2022-2029

Figure 11: Global Radiation Toxicity Treatment Market Share Analysis (%), By Indication, 2022 & 2029

Figure 12: Global Radiation Toxicity Treatment Market Y-o-Y Analysis (%), By Indication, 2022-2029

Figure 13: Global Radiation Toxicity Treatment Market Attractiveness Analysis by Indication, 2022-2029

Figure 14: Global Radiation Toxicity Treatment Market Share Analysis (%), By Radiation, 2022 & 2029

Figure 15: Global Radiation Toxicity Treatment Market Y-o-Y Analysis (%), By Radiation, 2022-2029

Figure 16: Global Radiation Toxicity Treatment Market Attractiveness Analysis by Radiation, 2022-2029

Figure 17: Global Radiation Toxicity Treatment Market Share Analysis (%), By End User, 2022 & 2029

Figure 18: Global Radiation Toxicity Treatment Market Y-o-Y Analysis (%), By End User, 2022-2029

Figure 19: Global Radiation Toxicity Treatment Market Attractiveness Analysis by End User, 2022-2029

Figure 20: Global Radiation Toxicity Treatment Market Share Analysis (%), By Region, 2022 & 2029

Figure 21: Global Radiation Toxicity Treatment Market Y-o-Y Analysis (%), By Country, 2022-2029

Figure 22: Global Radiation Toxicity Treatment Market Attractiveness Analysis by Region, 2022-2029

Figure 23: North America Radiation Toxicity Treatment Market Value Share, By Product, 2022 (E)

Figure 24: North America Radiation Toxicity Treatment Market Value Share, By Indication, 2022 (E)

Figure 25: North America Radiation Toxicity Treatment Market Value Share, By Radiation, 2022 (E)

Figure 26: North America Radiation Toxicity Treatment Market Value Share, By End User, 2022 (E)

Figure 27: North America Radiation Toxicity Treatment Market Value Share, By Country, 2022 (E)

Figure 28: North America Radiation Toxicity Treatment Market Value Analysis (US$ Mn), 2014-2021 

Figure 29: North America Radiation Toxicity Treatment Market Value Forecast (US$ Mn), 2022-2029

Figure 30: North America Radiation Toxicity Treatment Market Attractiveness Analysis by Product, 2022-2029

Figure 31: North America Radiation Toxicity Treatment Market Attractiveness Analysis by Indication, 2022-2029

Figure 32: North America Radiation Toxicity Treatment Market Attractiveness Analysis by Radiation, 2022-2029

Figure 33: North America Radiation Toxicity Treatment Market Attractiveness Analysis by End User, 2022-2029

Figure 34: North America Radiation Toxicity Treatment Market Attractiveness Analysis by Country, 2022-2029

Figure 35: Latin America Radiation Toxicity Treatment Market Value Share, By Product, 2022 (E)

Figure 36: Latin America Radiation Toxicity Treatment Market Value Share, By Indication, 2022 (E)

Figure 37: Latin America Radiation Toxicity Treatment Market Value Share, By Radiation, 2022 (E)

Figure 38: Latin America Radiation Toxicity Treatment Market Value Share, By End User, 2022 (E)

Figure 39: Latin America Radiation Toxicity Treatment Market Value Share, By Country, 2022 (E)

Figure 40: Latin America Radiation Toxicity Treatment Market Value Analysis (US$ Mn), 2014-2021 

Figure 41: Latin America Radiation Toxicity Treatment Market Value Forecast (US$ Mn), 2022-2029

Figure 42: Latin America Radiation Toxicity Treatment Market Attractiveness Analysis by Product, 2022-2029

Figure 43: Latin America Radiation Toxicity Treatment Market Attractiveness Analysis by Indication, 2022-2029

Figure 44: Latin America Radiation Toxicity Treatment Market Attractiveness Analysis by Radiation, 2022-2029

Figure 45: Latin America Radiation Toxicity Treatment Market Attractiveness Analysis by End User, 2022-2029

Figure 46: Latin America Radiation Toxicity Treatment Market Attractiveness Analysis by Country, 2022-2029

Figure 47: Europe Radiation Toxicity Treatment Market Value Share, By Product, 2022 (E)

Figure 48: Europe Radiation Toxicity Treatment Market Value Share, By Indication, 2022 (E)

Figure 49: Europe Radiation Toxicity Treatment Market Value Share, By Radiation, 2022 (E)

Figure 50: Europe Radiation Toxicity Treatment Market Value Share, By End User, 2022 (E)

Figure 51: Europe Radiation Toxicity Treatment Market Value Share, By Country, 2022 (E)

Figure 52: Europe Radiation Toxicity Treatment Market Value Analysis (US$ Mn), 2014-2021 

Figure 53: Europe Radiation Toxicity Treatment Market Value Forecast (US$ Mn), 2022-2029

Figure 54: Europe Radiation Toxicity Treatment Market Attractiveness Analysis by Product, 2022-2029

Figure 55: Europe Radiation Toxicity Treatment Market Attractiveness Analysis by Indication, 2022-2029

Figure 56: Europe Radiation Toxicity Treatment Market Attractiveness Analysis by Radiation, 2022-2029

Figure 57: Europe Radiation Toxicity Treatment Market Attractiveness Analysis by End User, 2022-2029

Figure 58: Europe Radiation Toxicity Treatment Market Attractiveness Analysis by Country, 2022-2029

Figure 59: East Asia Radiation Toxicity Treatment Market Value Share, By Product, 2022 (E)

Figure 60: East Asia Radiation Toxicity Treatment Market Value Share, By Indication, 2022 (E)

Figure 61: East Asia Radiation Toxicity Treatment Market Value Share, By Radiation, 2022 (E)

Figure 62: East Asia Radiation Toxicity Treatment Market Value Share, By End User, 2022 (E)

Figure 63: East Asia Radiation Toxicity Treatment Market Value Share, By Country, 2022 (E)

Figure 64: East Asia Radiation Toxicity Treatment Market Value Analysis (US$ Mn), 2014-2021 

Figure 65: East Asia Radiation Toxicity Treatment Market Value Forecast (US$ Mn), 2022-2029

Figure 66: East Asia Radiation Toxicity Treatment Market Attractiveness Analysis by Product, 2022-2029

Figure 67: East Asia Radiation Toxicity Treatment Market Attractiveness Analysis by Indication, 2022-2029

Figure 68: East Asia Radiation Toxicity Treatment Market Attractiveness Analysis by Radiation, 2022-2029

Figure 69: East Asia Radiation Toxicity Treatment Market Attractiveness Analysis by End User, 2022-2029

Figure 70: East Asia Radiation Toxicity Treatment Market Attractiveness Analysis by Country, 2022-2029

Figure 71: South Asia Radiation Toxicity Treatment Market Value Share, By Product, 2022 (E)

Figure 72: South Asia Radiation Toxicity Treatment Market Value Share, By Indication, 2022 (E)

Figure 73: South Asia Radiation Toxicity Treatment Market Value Share, By Radiation, 2022 (E)

Figure 74: South Asia Radiation Toxicity Treatment Market Value Share, By End User, 2022 (E)

Figure 75: South Asia Radiation Toxicity Treatment Market Value Share, By Country, 2022 (E)

Figure 76: South Asia Radiation Toxicity Treatment Market Value Analysis (US$ Mn), 2014-2021 

Figure 77: South Asia Radiation Toxicity Treatment Market Value Forecast (US$ Mn), 2022-2029

Figure 78: South Asia Radiation Toxicity Treatment Market Attractiveness Analysis by Product, 2022-2029

Figure 79: South Asia Radiation Toxicity Treatment Market Attractiveness Analysis by Indication, 2022-2029

Figure 80: South Asia Radiation Toxicity Treatment Market Attractiveness Analysis by Radiation, 2022-2029

Figure 81: South Asia Radiation Toxicity Treatment Market Attractiveness Analysis by End User, 2022-2029

Figure 82: South Asia Radiation Toxicity Treatment Market Attractiveness Analysis by Country, 2022-2029

Figure 83: Oceania Radiation Toxicity Treatment Market Value Share, By Product, 2022 (E)

Figure 84: Oceania Radiation Toxicity Treatment Market Value Share, By Indication, 2022 (E)

Figure 85: Oceania Radiation Toxicity Treatment Market Value Share, By Radiation, 2022 (E)

Figure 86: Oceania Radiation Toxicity Treatment Market Value Share, By End User, 2022 (E)

Figure 87: Oceania Radiation Toxicity Treatment Market Value Share, By Country, 2022 (E)

Figure 88: Oceania Radiation Toxicity Treatment Market Value Analysis (US$ Mn), 2014-2021 

Figure 89: Oceania Radiation Toxicity Treatment Market Value Forecast (US$ Mn), 2022-2029

Figure 90: Oceania Radiation Toxicity Treatment Market Attractiveness Analysis by Product, 2022-2029

Figure 91: Oceania Radiation Toxicity Treatment Market Attractiveness Analysis by Indication, 2022-2029

Figure 92: Oceania Radiation Toxicity Treatment Market Attractiveness Analysis by Radiation, 2022-2029

Figure 93: Oceania Radiation Toxicity Treatment Market Attractiveness Analysis by End User, 2022-2029

Figure 94: Oceania Radiation Toxicity Treatment Market Attractiveness Analysis by Country, 2022-2029

Figure 95: MEA Radiation Toxicity Treatment Market Value Share, By Product, 2022 (E)

Figure 96: MEA Radiation Toxicity Treatment Market Value Share, By Indication, 2022 (E)

Figure 97: MEA Radiation Toxicity Treatment Market Value Share, By Radiation, 2022 (E)

Figure 98: MEA Radiation Toxicity Treatment Market Value Share, By End User, 2022 (E)

Figure 99: MEA Radiation Toxicity Treatment Market Value Share, By Country, 2022 (E)

Figure 100: MEA Radiation Toxicity Treatment Market Value Analysis (US$ Mn), 2014-2021 

Figure 101: MEA Radiation Toxicity Treatment Market Value Forecast (US$ Mn), 2022-2029

Figure 102: MEA Radiation Toxicity Treatment Market Attractiveness Analysis by Product, 2022-2029

Figure 103: MEA Radiation Toxicity Treatment Market Attractiveness Analysis by Indication, 2022-2029

Figure 104: MEA Radiation Toxicity Treatment Market Attractiveness Analysis by Radiation, 2022-2029

Figure 105: MEA Radiation Toxicity Treatment Market Attractiveness by End User, 2022-2029

Figure 106: MEA Radiation Toxicity Treatment Market Attractiveness Analysis by Country, 2022-2029

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Radiation Toxicity Treatment Market

Published : February 2022

Healthcare

Radiotherapy Patient Positioning Accessories Market

Published : February 2022

Healthcare

Radiation-Induced Myelosuppression Treatment Market

Published : January 2022

Healthcare

Superficial Radiation Therapy System Market

Published : February 2022

Google translate

Radiation Toxicity Treatment Market